NASDAQ:VAXX Vaxxinity - VAXX Institutional Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Vaxxinity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $2.26 -0.11 (-4.64%) (As of 03/22/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.23▼$2.4750-Day Range$1.94▼$4.2452-Week Range$1.24▼$8.35Volume76,088 shsAverage Volume367,882 shsMarket Capitalization$284.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Vaxxinity (NASDAQ:VAXX)CurrentInstitutional OwnershipPercentage20.84%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$3.95 MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$6.09 M Skip Chart & View Institutional Buying and Selling Data VAXX Institutional Buying and Selling by Quarter Get VAXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaxxinity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Vaxxinity Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2023Virtu Financial LLC17,842$25K0.0%N/A0.014% 2/15/2023Millennium Management LLC72,407$0.10M0.0%+348.0%0.057% 2/13/2023Renaissance Technologies LLC107,594$0.15M0.0%-41.4%0.085% 2/13/2023Geode Capital Management LLC350,357$0.49M0.0%+4.0%0.278% 2/10/2023Bank of America Corp DE552,423$0.77M0.0%-82.8%0.438% 11/15/2022Two Sigma Investments LP24,947$49K0.0%-80.6%0.020% 11/15/2022Vanguard Group Inc.2,212,186$4.38M0.0%+44.5%1.755% 11/15/2022Prime Movers Lab LLC17,603,276$31.37M22.6%-1.4%13.968% 11/15/2022Marshall Wace LLP178,258$0.35M0.0%-71.3%0.141% 11/15/2022BlackRock Inc.373,261$0.74M0.0%N/A0.296% 11/14/2022Renaissance Technologies LLC183,635$0.36M0.0%-30.0%0.146% 11/4/2022First Republic Investment Management Inc.199,022$0.39M0.0%N/A0.158% 8/16/2022Creative Planning277,521$0.44M0.0%N/A0.221% 8/15/2022Millennium Management LLC213,620$0.34M0.0%N/A0.170% 8/13/2022Renaissance Technologies LLC262,400$0.41M0.0%N/A0.209% 8/10/2022Clarius Group LLC20,000$31K0.0%N/A0.016% 7/22/2022Truist Financial Corp20,738$33K0.0%N/A0.016% 7/21/2022Hollencrest Capital Management20,000$31K0.0%N/A0.016% 6/7/2022Bank of America Corp DE15,858$68K0.0%+7,829.0%0.013% 5/16/2022Goldman Sachs Group Inc.97,069$0.42M0.0%-56.1%0.077% 5/13/2022Vanguard Group Inc.55,121$0.24M0.0%-8.1%0.044% 3/10/2022Prime Movers Lab LLC18,027,314$91.02M17.4%N/A14.377% 2/15/2022Adage Capital Partners GP L.L.C.1,001,670$5.62M0.0%N/A0.799% 2/14/2022ETF Managers Group LLC37,884$0.21M0.0%N/A0.030% 2/1/2022FNY Investment Advisers LLC4,847$27K0.0%N/A0.004% (Data available from 1/1/2016 forward) VAXX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VAXX shares? During the previous two years, 19 institutional investors and hedge funds held shares of Vaxxinity. The most heavily invested institutionals were Prime Movers Lab LLC ($31.37M), Adage Capital Partners GP L.L.C. ($5.62M), Vanguard Group Inc. ($4.38M), Bank of America Corp DE ($0.77M), BlackRock Inc. ($0.74M), Geode Capital Management LLC ($0.49M), and Creative Planning ($0.44M).Learn more on VAXX's institutional investors. What percentage of Vaxxinity stock is owned by institutional investors? 20.84% of Vaxxinity stock is owned by institutional investors. Learn more on VAXX's institutional investor holdings. Which institutional investors have been buying Vaxxinity stock? Of the 16 institutional investors that purchased Vaxxinity stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Prime Movers Lab LLC ($18.03M), Adage Capital Partners GP L.L.C. ($1M), Vanguard Group Inc. ($0.68M), BlackRock Inc. ($0.37M), Creative Planning ($0.28M), Millennium Management LLC ($0.27M), and Renaissance Technologies LLC ($0.26M). How much institutional buying is happening at Vaxxinity? Institutional investors have bought a total of 21,243,214 shares in the last 24 months. This purchase volume represents approximately $110.94M in transactions. Which Vaxxinity major shareholders have been selling company stock? The following institutional investors have sold Vaxxinity stock in the last 24 months: Bank of America Corp DE ($2.65M), Marshall Wace LLP ($0.44M), Prime Movers Lab LLC ($0.25M), Renaissance Technologies LLC ($0.15M), Goldman Sachs Group Inc. ($0.12M), Two Sigma Investments LP ($0.10M), and Vanguard Group Inc. ($4.88K). How much institutional selling is happening at Vaxxinity? Institutional investors have sold a total of 3,725,321 shares in the last 24 months. This volume of shares sold represents approximately $6.09M in transactions. This page (NASDAQ:VAXX) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.